Literature DB >> 10500213

Lps(d)/Ran of endotoxin-resistant C3H/HeJ mice is defective in mediating lipopolysaccharide endotoxin responses.

P M Wong1, A Kang, H Chen, Q Yuan, P Fan, B M Sultzer, Y W Kan, S W Chung.   

Abstract

C3H/HeJ inbred mice are defective in that they are highly resistant to endotoxic shock as compared with normal responder mice. Their B cells and macrophages do not respond significantly when exposed to lipopolysaccharide (LPS), whereas cells from the responder mice do. Using a functional assay, we previously isolated a cDNA, which encodes for Ran/TC4 GTPase. We now show that this gene is mutated in C3H/HeJ mice, which accounts for their resistance to endotoxin stimulation. Sequence analysis of independent mutant Lps(d)/Ran cDNAs isolated from splenic B cells of C3H/HeJ mice reveals a consistent single base substitution at position 870, where a thymidine is replaced with a cytidine. In situ hybridization maps the Lps(d)/Ran cDNA to mouse chromosome 4. By retroviral gene transfer, the wild-type Lps(n)/Ran cDNA but not the mutant Lps(d)/Ran cDNA can restore LPS responsiveness of C3H/HeJ cells. Adenoviral gene transfer in vivo with the mutant Lps(d)/Ran cDNA but not the wild-type Lps(n)/Ran cDNA rescues endotoxin-sensitive mice from septic shock. Thus Lps/Ran is an important target for LPS-mediated signal transduction, and the Lps(d)/Ran gene may be useful as a therapeutic sequence in gene therapy for endotoxemia and septic shock.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10500213      PMCID: PMC18070          DOI: 10.1073/pnas.96.20.11543

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  The response of recombinant inbred strains of mice to bacterial lipopolysaccharides.

Authors:  J Watson; R Riblet; B A Taylor
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

Review 2.  Bacterial endotoxins and host immune responses.

Authors:  D C Morrison; J L Ryan
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

3.  RNA binding and translational suppression by bicoid.

Authors:  R Rivera-Pomar; D Niessing; U Schmidt-Ott; W J Gehring; H Jäckle
Journal:  Nature       Date:  1996-02-22       Impact factor: 49.962

4.  High-efficiency cloning of full-length cDNA.

Authors:  H Okayama; P Berg
Journal:  Mol Cell Biol       Date:  1982-02       Impact factor: 4.272

5.  Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region.

Authors:  A Poltorak; I Smirnova; X He; M Y Liu; C Van Huffel; O McNally; D Birdwell; E Alejos; M Silva; X Du; P Thompson; E K Chan; J Ledesma; B Roe; S Clifton; S N Vogel; B Beutler
Journal:  Blood Cells Mol Dis       Date:  1998-09       Impact factor: 3.039

6.  Human RanGTPase-activating protein RanGAP1 is a homologue of yeast Rna1p involved in mRNA processing and transport.

Authors:  F R Bischoff; H Krebber; T Kempf; I Hermes; H Ponstingl
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Genetic control of B cell activation by bacterial lipopolysaccharide is mediated by multiple distinct genes or alleles.

Authors:  L M Glode; D L Rosenstreich
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

8.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

9.  Translation of 15-lipoxygenase mRNA is inhibited by a protein that binds to a repeated sequence in the 3' untranslated region.

Authors:  A Ostareck-Lederer; D H Ostareck; N Standart; B J Thiele
Journal:  EMBO J       Date:  1994-03-15       Impact factor: 11.598

10.  Genetic control of endotoxic responses in mice.

Authors:  J Watson; M Largen; K P McAdam
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

View more
  8 in total

1.  Dominant negative down-regulation of endotoxin-induced tumor necrosis factor alpha production by Lps(d)/Ran.

Authors:  Q Yuan; F Zhao; S W Chung; P Fan; B M Sultzer; Y W Kan; P M Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M.

Authors:  Jane C Deng; Genhong Cheng; Michael W Newstead; Xianying Zeng; Koichi Kobayashi; Richard A Flavell; Theodore J Standiford
Journal:  J Clin Invest       Date:  2006-08-17       Impact factor: 14.808

3.  Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells.

Authors:  Kuo-Ching Sheng; Dodie S Pouniotis; Mark D Wright; Choon Kit Tang; Eliada Lazoura; Geoffrey A Pietersz; Vasso Apostolopoulos
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

4.  Quantitative aspects of lipopolysaccharide and cytokine requirements to generate nitric oxide in macrophages from LPS-hyporesponsive (Lps(d)) C3H/HeJ mice.

Authors:  E Kmonícková; Z Zídek
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

5.  Toll-like receptor 4-deficient mice have reduced bone destruction following mixed anaerobic infection.

Authors:  L Hou; H Sasaki; P Stashenko
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

6.  Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice.

Authors:  A Pagenstecher; A K Stalder; C L Kincaid; B Volk; I L Campbell
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

7.  Differential expression of caveolin-1 in lipopolysaccharide-activated murine macrophages.

Authors:  M G Lei; D C Morrison
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

8.  Presence of Lps(d) mutation influences cytokine regulation in vivo by the Mycoplasma arthritidis mitogen superantigen and lethal toxicity in mice infected with M. arthritidis.

Authors:  H H Mu; A D Sawitzke; B C Cole
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.